Alexion Pharmaceuticals I...

NASDAQ: ALXN · Real-Time Price · USD
182.50
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Alexion Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2021
Period Ending Mar 31, 2021
Cash & Equivalents
3.43B
Short-Term Investments
39.7M
Long-Term Investments
n/a
Other Long-Term Assets
447M
Receivables
1.47B
Inventory
803.9M
Other Current Assets
706.4M
Total Current Assets
6.45B
Property-Plant & Equipment
1.46B
Goodwill & Intangibles
8.15B
Total Long-Term Assets
12.2B
Total Assets
18.65B
Account Payables
125.3M
Deferred Revenue
n/a
Short-Term Debt
143.2M
Other Current Liabilities
1.16B
Total Current Liabilities
1.43B
Long-Term Debt
2.39B
Other Long-Term Liabilities
765.1M
Total Long-Term Liabilities
4.79B
Total Liabilities
6.22B
Total Debt
2.53B
Common Stock
n/a
Retained Earnings
5.88B
Comprehensive Income
-85.2M
Shareholders Equity
12.42B
Total Investments
39.7M